Issue Information
23 July 2019
Issue Information ‐ Author Checklist
23 July 2019
Zinc Maintenance Therapy for Wilson Disease: A Comparison Between Zinc Acetate and Alternative Zinc Preparations
Michelle A. Camarata, Aftab Ala, Michael L. Schilsky – 23 July 2019 – We evaluate Wilson disease (WD) treatment with zinc acetate (U.S. Food and Drug Administration approved) and alternative zinc salts. Studies examining zinc therapy in WD are few, and data on alternative zinc salts are limited. We describe one of the largest recent studies of zinc therapy in WD.
Peribiliary Gland Niche Participates in Biliary Tree Regeneration in Mouse and in Human Primary Sclerosing Cholangitis
Guido Carpino, Lorenzo Nevi, Diletta Overi, Vincenzo Cardinale, Wei‐Yu Lu, Sabina Di Matteo, Samira Safarikia, Pasquale Bartolomeo Berloco, Rosanna Venere, Paolo Onori, Antonio Franchitto, Stuart J. Forbes, Domenico Alvaro, Eugenio Gaudio – 22 July 2019
Letter to the Editor: mTOR‐Inhibitor‐Based Immunosuppression Following Liver Transplantation for Hereditary Hemorrhagic Telangiectasia
Jose Castellote, José Maria Mora Luján, Antoni Riera‐Mestre – 22 July 2019
Letter to the Editor: Liver Transplantation for Acute Liver Failure Because of Dengue Fever: First Successful Reported Case Worldwide
Narendra S. Choudhary, Sanjiv Saigal, Arvinder S. Soin – 22 July 2019
The Mutational Features of Aristolochic Acid–Induced Mouse and Human Liver Cancers
Zhao‐Ning Lu, Qing Luo, Li‐Nan Zhao, Yi Shi, Na Wang, Lan Wang, Ze‐Guang Han – 20 July 2019
Low Levels of Alcohol Consumption, Obesity, and Development of Fatty Liver With and Without Evidence of Advanced Fibrosis
Yoosoo Chang, Seungho Ryu, Yejin Kim, Yong Kyun Cho, Eunju Sung, Han‐Na Kim, Jiin Ahn, Hyun‐Suk Jung, Kyung Eun Yun, Seolhye Kim, Ki‐Chul Sung, Chong Il Sohn, Hocheol Shin, Sarah H. Wild, Christopher D. Byrne – 19 July 2019
Reply
Mussarat N. Rahim, Michael A. Heneghan – 19 July 2019
Interleukin‐32 Contributes to Human Nonalcoholic Fatty Liver Disease and Insulin Resistance
Nassim Dali‐Youcef, Michel Vix, Federico Costantino, Houssein El‐Saghire, Benoit Lhermitte, Cosimo Callari, Jacopo D’Agostino, Silvana Perretta, Stefan Paveliu, Monica Gualtierotti, Edith Dumeny, Marine A. Oudot, Amélie Jaulin, Doulaye Dembélé, Mirjam B. Zeisel, Catherine Tomasetto, Thomas F. Baumert, Michel Doffoël – 19 July 2019 – Nonalcoholic fatty liver disease (NAFLD) is a metabolic disorder due to increased accumulation of fat in the liver and in many cases to enhanced inflammation.